These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2567192)

  • 1. In what circumstances is it justifiable to prescribe concomitant misoprostol and/or H2-receptor blockers with non-steroidal anti-inflammatory drugs?
    Roth SH
    Br J Rheumatol; 1989 Jun; 28(3):211. PubMed ID: 2567192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of NSAID-induced gastric lesions: H2 antagonists or misoprostol? A meta-analysis of controlled clinical studies].
    Capurso L; Koch M
    Clin Ter; 1991 Dec 15-31; 139(5-6):179-89. PubMed ID: 1686995
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 4. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. There's the forest. The object lesson of NSAID "gastropathy".
    Hadler NM
    J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Knol A
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2339. PubMed ID: 10589226
    [No Abstract]   [Full Text] [Related]  

  • 7. Misoprostol and NSAID ulcers.
    Isaacs P
    Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
    Miederer SE
    Fortschr Med; 1989 Mar; 107(10):63-4, 67-8. PubMed ID: 2497057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol and ulcer prophylaxis.
    Upadhyay R; Taha AS; Sturrock RD; Russell RI
    Lancet; 1989 Jan; 1(8631):212-3. PubMed ID: 2563111
    [No Abstract]   [Full Text] [Related]  

  • 12. NSAIDs, misoprostol, and gastrointestinal bleeding.
    Shield MJ
    Lancet; 1991 May; 337(8751):1221-2. PubMed ID: 1673756
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
    Kato M; Kamada G; Yamamoto K; Nishida U; Imai A; Yoshida T; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1631-5. PubMed ID: 20880171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
    Vakhrushev IaM; Loshchakova OIu
    Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol in treatment of gastropathy due to nonsteroidal anti-inflammatory drugs.
    Blackburn WD; Alarcon GS
    Am J Med; 1990 Jan; 88(1):85. PubMed ID: 2104742
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nonsteroidal, anti-inflammatory, drug-associated dyspepsia.
    Gupta S; McQuaid K
    Gastroenterology; 2005 Nov; 129(5):1711-9. PubMed ID: 16285968
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.